- Home
- DSS vs BFRI Comparison
DSS vs BFRI Comparison
Compare DSS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- BFRI
- Stock Information
- Founded
- DSS 1984
- BFRI 1997
- Country
- DSS United States
- BFRI United States
- Employees
- DSS N/A
- BFRI N/A
- Industry
- DSS Containers/Packaging
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- BFRI Health Care
- Exchange
- DSS Nasdaq
- BFRI Nasdaq
- Market Cap
- DSS 7.3M
- BFRI 8.7M
- IPO Year
- DSS N/A
- BFRI 2021
- Fundamental
- Price
- DSS $0.87
- BFRI $0.79
- Analyst Decision
- DSS
- BFRI Strong Buy
- Analyst Count
- DSS 0
- BFRI 1
- Target Price
- DSS N/A
- BFRI $7.00
- AVG Volume (30 Days)
- DSS 82.9K
- BFRI 90.7K
- Earning Date
- DSS 03-31-2025
- BFRI 03-21-2025
- Dividend Yield
- DSS N/A
- BFRI N/A
- EPS Growth
- DSS N/A
- BFRI N/A
- EPS
- DSS N/A
- BFRI N/A
- Revenue
- DSS $19,097,000.00
- BFRI $37,321,000.00
- Revenue This Year
- DSS N/A
- BFRI $28.62
- Revenue Next Year
- DSS N/A
- BFRI $27.07
- P/E Ratio
- DSS N/A
- BFRI N/A
- Revenue Growth
- DSS N/A
- BFRI 9.54
- 52 Week Low
- DSS $0.77
- BFRI $0.65
- 52 Week High
- DSS $2.30
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- DSS 43.96
- BFRI 34.82
- Support Level
- DSS $0.78
- BFRI $0.81
- Resistance Level
- DSS $1.03
- BFRI $0.96
- Average True Range (ATR)
- DSS 0.10
- BFRI 0.08
- MACD
- DSS -0.00
- BFRI -0.01
- Stochastic Oscillator
- DSS 25.97
- BFRI 0.00
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.